FDA cleared the Symmetrix™ PX Spinal System from Medtronic Sofamor Danek USA, Inc. on Oct 29, 2026 under K262572, a traditional 510(k). The device falls under product code MAX, Intervertebral Fusion Device With Bone Graft, Lumbar, regulated at 21 CFR 888.3080 as a Class 2 device. The review panel was Orthopedic.

FDA logged the submission as received on Jul 27, 2026. The decision came 94 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Medtronic Sofamor Danek USA, Inc. has 6 other decisions in the tracker over the last 12 months: K253011 (Catalyft PL Expandable Interbody System), K261020 (Symmetrix™ L Spinal System), K253656 (OsteoCool™ RF Ablation System; OsteoCool™ 2.0 RF Ablation System), K260216 (CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System).